Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rixe

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancerM Spielmann, A Llombart, L Zelek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectivesJ P Spano, R Fagard, J-C Soria, et al.
Bulletin Du Cancer|May 13, 2009
[Angiogenesis: a new therapeutic target of thoracic and laryngopharyngeal carcinoma]L Taillade, I Alexandre, B Billemont, et al.
Gene Therapy|October 1, 1996
In vitro sensitization of the B16 murine melanoma cells to ganciclovir by different RNA and plasmid DNA constructions encoding HSVtkS V Yarovoi, R Mouawad, F Colbère-Garapin, et al.
Biochemical Pharmacology|December 24, 1996
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panelO Rixe, W Ortuzar, M Alvarez, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1995
[Adjuvant therapy of surgically removed stage I melanoma]M Weil, C Borel, O Rixe, et al.
Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.
La Revue De Medecine Interne|July 29, 2006
[Choroidal metastasis revealing pulmonary adenocarcinoma]N Tazi, D Le Thi Huong, B Bodaghi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 8, 2008
[Regression of vena cava tumour thrombus in response to sorafenib]F Thibault, H Izzedine, V Sultan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 13, 2009
[Primary carcinoma of the head of the epididymis]F Thibault, S Bart, O Rixe, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancerM Spielmann, A Llombart, L Zelek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectivesJ P Spano, R Fagard, J-C Soria, et al.
Bulletin Du Cancer|May 13, 2009
[Angiogenesis: a new therapeutic target of thoracic and laryngopharyngeal carcinoma]L Taillade, I Alexandre, B Billemont, et al.
Gene Therapy|October 1, 1996
In vitro sensitization of the B16 murine melanoma cells to ganciclovir by different RNA and plasmid DNA constructions encoding HSVtkS V Yarovoi, R Mouawad, F Colbère-Garapin, et al.
Biochemical Pharmacology|December 24, 1996
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panelO Rixe, W Ortuzar, M Alvarez, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1995
[Adjuvant therapy of surgically removed stage I melanoma]M Weil, C Borel, O Rixe, et al.
Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.
La Revue De Medecine Interne|July 29, 2006
[Choroidal metastasis revealing pulmonary adenocarcinoma]N Tazi, D Le Thi Huong, B Bodaghi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 8, 2008
[Regression of vena cava tumour thrombus in response to sorafenib]F Thibault, H Izzedine, V Sultan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 13, 2009
[Primary carcinoma of the head of the epididymis]F Thibault, S Bart, O Rixe, et al.
Pageof 7